Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series-Reference-Cited by-同舟云学术

Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series

Author:

Tremblay Zoë¹,Wong Anna¹,Otis Anne‐Sophie¹,Pépin Marie‐Anne¹,Bambace Nadia²,Soulières Denis³⁴,Bouchard Philippe⁵,Adam Jean‐Philippe⁴⁶^ORCID

Affiliation:

1. Faculty of Pharmacy Université de Montréal Montreal QC Canada

2. Division of Hemato‐Oncology Hôpital Maisonneuve‐Rosemont Montreal QC Canada

3. Division of Hematology‐Oncology Centre hospitalier de l'Université de Montréal Montreal QC Canada

4. Centre de recherche du Centre hospitalier de l'Université de Montréal Montreal QC Canada

5. Department of Pharmacy Hôpital Maisonneuve‐Rosemont Montreal QC Canada

6. Department of Pharmacy Centre hospitalier de l'Université de Montréal Montreal QC Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

Reference6 articles.

4. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3;Stone RM;Mutation,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Acute leukemias of ambiguous lineage;Cases in Laboratory Genetics and Genomics (LGG) Practice;2023